Why Pfizer Is Pulling Back on Research Into Rare Disease, Gene Therapy

Pfizer is planning to pull back on early-stage research into treatments for rare diseases, including the development of new viral-based gene therapies, the company told employees on Thursday afternoon. The company said it would “externalize” most of its early-stage rare disease programs in…#northcarolina #durham
Source: Reuters: Health - Category: Consumer Health News Source Type: news